...
首页> 外文期刊>Journal of Clinical Microbiology >Genotype MTBDRplus for Direct Detection of Mycobacterium tuberculosis and Drug Resistance in Strains from Gold Miners in South Africa
【24h】

Genotype MTBDRplus for Direct Detection of Mycobacterium tuberculosis and Drug Resistance in Strains from Gold Miners in South Africa

机译:基因型MTBDRplus,可直接检测南非金矿产菌株的结核分枝杆菌和耐药性

获取原文
   

获取外文期刊封面封底 >>

       

摘要

GenoType MTBDRplus is a molecular assay for detection of Mycobacterium tuberculosis and drug resistance. Assay performance as applied directly to consecutive unselected sputum samples has not been established. The objective of this study was to determine the accuracy of the MTBDRplus test for direct detection of M. tuberculosis (in sputum) and for drug resistance in consecutively submitted sputum samples. In this cross-sectional study in South Africa, one sputum specimen from each person suspected of having pulmonary tuberculosis was tested by smear microscopy, direct MTBDRplus, and Mycobacterial Growth Indicator Tube (MGIT) culture with MGIT drug susceptibility testing. MGIT results were the reference standard. We tested 2,510 sputum samples, and 529 (21.1%) were positive for M. tuberculosis by MGIT. Direct MTBDRplus identified M. tuberculosis in 256 of 529 specimens (sensitivity, 48.4%; 95% confidence interval [CI], 44.1, 52.7). The sensitivity of MTBDRplus for M. tuberculosis detection by sputum smear status was as follows: smear negative, 13.7% (95% CI, 9.8, 18.4); smear scanty, 46.2% (95% CI, 19.2, 74.9); smear 1+, 69.1% (95% CI, 55.2, 80.9); smear 2+, 86.3% (95% CI, 73.7, 94.3); smear 3+, 89.8% (95% CI, 83.7, 94.2). Direct MTBDRplus testing was negative for 1,594/1,612 sputum samples that were culture negative for M. tuberculosis (specificity, 98.9%; 95% CI, 98.2, 99.3). For specimens positive for M. tuberculosis by MTBDRplus, this assay's sensitivity and specificity for rifampin resistance were 85.7% (95% CI, 57.2, 98.2) and 96.6% (95% CI, 93.2, 98.6) and for isoniazid resistance they were 62.1% (95% CI, 42.3, 79.3) and 97.9% (95% CI, 94.8, 99.4). For sputum testing, the sensitivity of MTBDRplus is directly related to the specimen's bacillary burden. Our results support recommendations that the MTBDRplus test not be used for direct testing of smear-negative or paucibacillary sputum samples.
机译:GenoType MTBDRplus是用于检测结核分枝杆菌和耐药性的分子检测方法。尚未确定直接应用于连续未选择痰液样本的测定性能。这项研究的目的是确定MTBDRplus测试在直接提交痰标本中直接检测结核分枝杆菌(在痰中)和耐药性的准确性。在南非的这项横断面研究中,通过涂片显微镜检查,直接MTBDRplus和分枝杆菌生长指示剂管(MGIT)培养与MGIT药物敏感性测试,对每个怀疑患有肺结核的人的痰标本进行了测试。 MGIT结果为参考标准。我们测试了2,510份痰液样本,其中529份(21.1%)的MGIT呈阳性。直接MTBDRplus在529个样本中的256个中鉴定出结核分枝杆菌(敏感性,48.4%; 95%置信区间[CI],44.1,52.7)。 MTBDRplus通过痰涂片状态检测结核分枝杆菌的敏感性如下:涂片阴性,13.7%(95%CI,9.8、18.4);涂片稀少46.2%(95%CI,19.2,74.9);涂抹1+,69.1%(95%CI,55.2,80.9);涂抹2+,86.3%(95%CI,73.7,94.3);涂抹3+,89.8%(95%CI,83.7,94.2)。直接MTBDRplus测试对1,594 / 1,612痰标本为结核分枝杆菌培养阴性的痰标​​本为阴性(特异性,98.9%; 95%CI,98.2,99.3)。对于MTBDRplus对结核分枝杆菌呈阳性的标本,该测定法对利福平耐药的敏感性和特异性分别为85.7%(95%CI,57.2、98.2)和96.6%(95%CI,93.2、98.6),对异烟肼耐药性则为62.1% (95%CI,42.3、79.3)和97.9%(95%CI,94.8、99.4)。对于痰液测试,MTBDRplus的敏感性与标本的细菌负担直接相关。我们的结果支持建议不要将MTBDRplus测试直接用于涂片阴性或脓胸痰标本的测试。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号